hantavir.us
Active outbreaks

Diagnosis β€” Hantavirus

Why hantavirus diagnosis is difficult

Hantavirus infection is notoriously difficult to diagnose in its early stages. The prodromal symptoms β€” fever, fatigue, myalgia, headache, and gastrointestinal complaints β€” are indistinguishable from influenza, COVID-19, leptospirosis, rickettsial diseases, and early bacterial sepsis.

The critical clinical clue is rodent exposure history in the preceding 1–8 weeks. Healthcare providers in endemic areas should maintain a high index of suspicion and ask patients about:

  • Recent cleaning of rodent-infested buildings (barns, cabins, sheds)
  • Exposure to rural or wilderness areas
  • Known hantavirus cases in the community
  • Occupational exposure (farmers, forestry workers, pest control)

Laboratory confirmation

TestTimingWhat it detectsNotes
IgM ELISADay 1–3 of symptomsAnti-hantavirus IgM antibodiesMost common screening test; confirmatory
IgG ELISADay 7+Anti-hantavirus IgG antibodiesIndicates past or resolving infection
RT-PCRAcute phase (early)Viral RNA in blood or tissueHighly specific; strain identification possible
Immunohistochemistry (IHC)Post-mortem or biopsyViral antigen in tissueGold standard for fatal cases
Focus reduction neutralisation test (FRNT)ConvalescentNeutralising antibodies (strain-specific)Reference standard; not widely available

Supporting clinical findings

  • Thrombocytopenia (low platelets) β€” found in virtually all HPS patients
  • Leukocytosis with left shift (elevated white blood cells)
  • Hemoconcentration (elevated haematocrit)
  • Elevated LDH and AST
  • Proteinuria (protein in urine) β€” especially in HFRS
  • Bilateral pulmonary infiltrates on chest X-ray (HPS)

When to suspect hantavirus

The CDC recommends considering hantavirus testing when a patient presents with:

  1. Fever AND
  2. Pulmonary infiltrates (HPS) or acute kidney injury (HFRS) AND
  3. History of potential rodent exposure in the Americas or Eurasia

Sources

  1. CDC. Diagnosing HPS. CDC Diagnosis
  2. Knust B, Rollin PE. Twenty-year summary of surveillance for human hantavirus infections, United States. Emerg Infect Dis 2013;19(12):1934-1937.
  3. Hjelle B, Torres-PΓ©rez F. Hantaviruses in the Americas. Antiviral Res 2010.

Reviewed by: Hantavirus Editorial

Last reviewed: 2026-05-10